Владислав Владимирович Петкау
79 works · 172 citations · h-index 7
Top works
- Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry
- Five-year overall survival among patients with metastatic renal cell carcinoma: Results of Russian population-based study RENSUR5.
- Life expectancy in patients with metastatic renal cell carcinoma in the Russian Federation: results of the RENSUR3 multicenter registry study
- Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry
- Regional introduction of work support system of the oncological service
- Практические рекомендации по лекарственному лечению больных гепатоцеллюлярным раком
- Impact of a multidisciplinary approach and patient routing on the outcomes of treatment of patients with hepatocellular cancer
- Практические рекомендации по лекарственному лечению больных злокачественными опухолями печени и желчевыводящей системы
- Злокачественные опухоли печени и желчевыводящей системы
- Cost of supportive cancer care in the Russian Federation. Part 1
- Current State of Incidence and Diagnosis of Melanoma and Other Malignant Neoplasms of the Skin in the Russian Federation and the Ural Federal District
- Cause analysis of post-mortem diagnosis of hepatocellular carcinoma
- Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real‐World, Ambispective RAVE ‐Bladder Study
- Survival of patients with metastatic bladder cancer in the Russian Federation: results of a multicenter registry study URRU
- CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer
- Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study
- The association of access to systemic therapy and overall survival in metastatic bladder cancer in Russia: An analysis of URRU register.
- Unresectable hepatocellular carcinoma: prospects for drug therapy with lenvatinib
- Interim results from a real-world ambispective study RAVE-Bladder: avelumab first-line maintenance therapy in patients with metastatic urothelial carcinoma
- Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study